Viewing Study NCT02414750


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-02-20 @ 6:39 PM
Study NCT ID: NCT02414750
Status: TERMINATED
Last Update Posted: 2022-11-30
First Post: 2015-02-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vemurafenib Plus Cobimetinib in Metastatic Melanoma
Sponsor: Netherlands Working Group on Immunotherapy of Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module